MetaCap

agilon health inc. (AGL) vs Progyny (PGNY)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

agilon health inc. (AGL) has outperformed Progyny (PGNY) over the past year, gaining 481.3% versus a gain of 38.1%. Over five years, PGNY leads with a -30.1% price change compared with -83.3% for AGL. Progyny is the larger company by market cap ($2.63 billion vs $1.52 billion), about 1.7 times the size.

On valuation, Progyny trades at a lower forward P/E (14.9x vs 20.7x for agilon health inc.). Progyny converts more of its revenue into profit, with a net margin of 4.5% versus -6.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AGL+481.26%PGNY+38.09%
+776%+344%-88%
Nov 21, 20251 yearNov 20, 2026
AGL-84.81%PGNY-39.83%
+27%-39%-104%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AGL versus PGNY key metrics
MetricAGLPGNY
Share price$90.24$35.71
Market cap$1.52B$2.63B
1-day change+0.83%+0.73%
YTD return+423.89%+39.06%
1-year return+481.26%+38.09%
5-year return-83.28%-30.08%
P/E ratio (TTM)—32.76
Forward P/E20.7014.87
EPS (TTM)$-6.69$1.09
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$5.93B$1.29B
Revenue growth (YoY)-2.11%+10.40%
Net income (latest FY)$-391.35M$58.52M
Gross margin—23.63%
Operating margin-7.81%6.62%
Net margin-6.60%4.54%
52-week high$133.04$37.21
52-week low$7.48$16.10
Distance from 52-week high-32.17%-4.03%
Analyst consensusbuystrong_buy
Avg. price target upside+38.33%+5.71%
Average volume226.26K1.10M
Shares outstanding16.80M73.65M
Employees856835
SectorHealth CareHealth Care
IndustryMisc Health and Biotechnology ServicesMisc Health and Biotechnology Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • AGL has outperformed PGNY by 443.2 percentage points over the past year.
  • Progyny is more profitable, keeping 4.5 cents of every revenue dollar as net income versus -6.6 cents for agilon health inc..
  • Progyny grew revenue faster in its latest fiscal year (+10.40% vs -2.11%).

About agilon health inc.

AGL stock →

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States.

Health Care · Misc Health and Biotechnology Services · 856 employees

About Progyny

PGNY stock →

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists.

Health Care · Misc Health and Biotechnology Services · 835 employees

AGL vs PGNY FAQ

Which is bigger, agilon health inc. or Progyny?

Progyny (PGNY) is larger, with a market capitalization of $2.63B compared with $1.52B for agilon health inc. (AGL).

Which stock has performed better over the past year, AGL or PGNY?

AGL returned +481.26% over the past 12 months, compared with +38.09% for PGNY (price return, excluding dividends). Past performance does not predict future results.

Are agilon health inc. and Progyny in the same industry?

Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.

More comparisons